Home › Funds › Citigroup Inc › BBOT
Citigroup Inc position in BBOT
BRIDGEBIO ONCOLOGY THERAPEUT · Health Care
Latest position (Q2 2026)19.87K sh
Reported value held$151.43K
Portfolio Weight0.00%
First reportedQ2 2026
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 19.87K | $151.43K | New |
Other funds holding BBOT
- Wellington Management Group 2.79M sh · $21.25M · Q2 2026
- Citadel Advisors 2.62M sh · $19.95M · Q2 2026
- BlackRock Inc 2.15M sh · $16.41M · Q2 2026
- Vanguard Group 791.10K sh · $9.90M · Q4 2025
- Geode Capital Management 622.35K sh · $4.74M · Q2 2026
- Royce & Associates 384.94K sh · $2.93M · Q2 2026
- Charles Schwab Investment Management 286.52K sh · $2.18M · Q2 2026
- Casdin Capital 282.31K sh · $2.15M · Q2 2026
- Fidelity Management & Research (FMR) 240.59K sh · $1.83M · Q2 2026
- Northern Trust Corp 186.48K sh · $1.42M · Q2 2026
- UBS Group AG 114.66K sh · $873.67K · Q2 2026
- Millennium Management 105.48K sh · $803.76K · Q2 2026